Literature DB >> 24323081

Induction of antigen-positive cell death by the expression of perforin, but not DTa, from a DNA vaccine enhances the immune response.

Tessa Gargett1, Branka Grubor-Bauk1, Tamsin J Garrod1, Wenbo Yu1, Darren Miller2, Lee Major3, Steve Wesselingh4, Andreas Suhrbier3, Eric J Gowans1.   

Abstract

The failure of traditional protein-based vaccines to prevent infection by viruses such as HIV or hepatitis C highlights the need for novel vaccine strategies. DNA vaccines have shown promise in small animal models, and are effective at generating anti-viral T cell-mediated immune responses; however, they have proved to be poorly immunogenic in clinical trials. We propose that the induction of necrosis will enhance the immune response to vaccine antigens encoded by DNA vaccines, as necrotic cells are known to release a range of intracellular factors that lead to dendritic cell (DC) activation and enhanced cross-presentation of antigen. Here we provide evidence that induction of cell death in DNA vaccine-targeted cells provides an adjuvant effect following intradermal vaccination of mice; however, this enhancement of the immune response is dependent on both the mechanism and timing of cell death after antigen expression. We report that a DNA vaccine encoding the cytolytic protein, perforin, resulted in DC activation, enhanced broad and multifunctional CD8 T-cell responses to the HIV-1 antigen GAG and reduced viral load following challenge with a chimeric virus, EcoHIV, compared with the canonical GAG DNA vaccine. This effect was not observed for a DNA vaccine encoding an apoptosis-inducing toxin, DTa, or when the level of perforin expression was increased to induce cell death sooner after vaccination. Thus, inducing lytic cell death following a threshold level of expression of a viral antigen can improve the immunogenicity of DNA vaccines, whereas apoptotic cell death has an inhibitory effect on the immune response.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24323081     DOI: 10.1038/icb.2013.93

Source DB:  PubMed          Journal:  Immunol Cell Biol        ISSN: 0818-9641            Impact factor:   5.126


  18 in total

1.  Immunology & Cell Biology Publication of the Year Awards 2014.

Authors:  Gabrielle Belz
Journal:  Immunol Cell Biol       Date:  2015-11       Impact factor: 5.126

Review 2.  Encoded novel forms of HSP70 or a cytolytic protein increase DNA vaccine potency.

Authors:  Tamsin Garrod; Branka Grubor-Bauk; Stanley Yu; Tessa Gargett; Eric J Gowans
Journal:  Hum Vaccin Immunother       Date:  2014-11-19       Impact factor: 3.452

3.  A Multiantigenic DNA Vaccine That Induces Broad Hepatitis C Virus-Specific T-Cell Responses in Mice.

Authors:  Jason Gummow; Yanrui Li; Wenbo Yu; Tamsin Garrod; Danushka Wijesundara; Amelia J Brennan; Ranajoy Mullick; Ilia Voskoboinik; Branka Grubor-Bauk; Eric J Gowans
Journal:  J Virol       Date:  2015-05-27       Impact factor: 5.103

Review 4.  Perforin: An intriguing protein in allograft rejection immunology (Review).

Authors:  Ana-Maria Pașatu-Cornea; Elena Ciciu; Liliana-Ana Tuță
Journal:  Exp Ther Med       Date:  2022-06-15       Impact factor: 2.751

5.  Intradermal delivery of DNA encoding HCV NS3 and perforin elicits robust cell-mediated immunity in mice and pigs.

Authors:  B Grubor-Bauk; W Yu; D Wijesundara; J Gummow; T Garrod; A J Brennan; I Voskoboinik; E J Gowans
Journal:  Gene Ther       Date:  2015-10-01       Impact factor: 5.250

6.  Single-Dose Vaccination with a Hepatotropic Adeno-associated Virus Efficiently Localizes T Cell Immunity in the Liver with the Potential To Confer Rapid Protection against Hepatitis C Virus.

Authors:  Zelalem A Mekonnen; Branka Grubor-Bauk; Kieran English; Preston Leung; Makutiro G Masavuli; Ashish C Shrestha; Patrick Bertolino; David G Bowen; Andrew R Lloyd; Eric J Gowans; Danushka K Wijesundara
Journal:  J Virol       Date:  2019-09-12       Impact factor: 5.103

7.  Induction of Genotype Cross-Reactive, Hepatitis C Virus-Specific, Cell-Mediated Immunity in DNA-Vaccinated Mice.

Authors:  Danushka K Wijesundara; Jason Gummow; Eric J Gowans; Branka Grubor-Bauk; Yanrui Li; Wenbo Yu; Benjamin J Quah; Charani Ranasinghe; Joseph Torresi
Journal:  J Virol       Date:  2018-03-28       Impact factor: 5.103

8.  Increase in DNA vaccine efficacy by virosome delivery and co-expression of a cytolytic protein.

Authors:  Tessa Gargett; Branka Grubor-Bauk; Darren Miller; Tamsin Garrod; Stanley Yu; Steve Wesselingh; Andreas Suhrbier; Eric J Gowans
Journal:  Clin Transl Immunology       Date:  2014-06-27

9.  A HIV-Tat/C4-binding protein chimera encoded by a DNA vaccine is highly immunogenic and contains acute EcoHIV infection in mice.

Authors:  Khamis Tomusange; Danushka Wijesundara; Jason Gummow; Tamsin Garrod; Yanrui Li; Lachlan Gray; Melissa Churchill; Branka Grubor-Bauk; Eric J Gowans
Journal:  Sci Rep       Date:  2016-06-30       Impact factor: 4.379

10.  Mucosal vaccination with a live recombinant rhinovirus followed by intradermal DNA administration elicits potent and protective HIV-specific immune responses.

Authors:  Khamis Tomusange; Danushka Wijesundara; Jason Gummow; Steve Wesselingh; Andreas Suhrbier; Eric J Gowans; Branka Grubor-Bauk
Journal:  Sci Rep       Date:  2016-11-17       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.